Todos Medical Ltd (TOMDF)

Todos Medical Ltd. is a healthcare company focused on vitro diagnostics and other blood-based testing technologies. The company develops and commercializes tests in the United States for cancer and Alzheimer’s disease detection, including its Total Biochemical Infrared Analysis platform, which uses peripheral blood spectroscopy to study cancer’s effects on the immune system. It also develops the Lymphocyte Proliferation Test, designed to assess how peripheral blood lymphocytes and monocytes respond to mitogenic stimulation, along with diagnostic blood tests for neurodegenerative disorders. Its cancer-screening portfolio includes TM-B1 and TM-B2 for breast cancer and the TMC blood test for colon cancer screening and diagnosis. In addition, Todos Medical offers Tollovid, a dietary supplement intended to support immune function, and Tollovir, an antiviral treatment for COVID-19 that is in Phase 2 clinical trials. The company has collaboration and distribution arrangements related to SARS-CoV-2 testing, and it is headquartered in Tel Aviv-Yafo, Israel.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.